|Year : 2016 | Volume
| Issue : 5 | Page : 652-658
Isolation & characterization of Brucella melitensis isolated from patients suspected for human brucellosis in India
Anita Barua1, Ashu Kumar1, Duraipandian Thavaselvam1, Smita Mangalgi2, Archana Prakash1, Sapana Tiwari1, Sonia Arora1, Kannusamy Sathyaseelan1
1 Microbiology Division, Defence Research and Development Establishment, Gwalior, Bijapur, India
2 Microbiology Division, Shri BM Patil Medical College, BLDE University, Bijapur, India
|Date of Submission||26-Dec-2013|
|Date of Web Publication||28-Jul-2016|
Dr Duraipandian Thavaselvam
Microbiology Division, Defence Research & Development Establishment, Jhansi Road, Gwalior 474 002, Madhya Pradesh
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background & objectives: Brucellosis is endemic in the southern part of India. A combination of biochemical, serological and molecular methods is required for identification and biotyping of Brucella. The present study describes the isolation and biochemical, molecular characterization of Brucella melitensis from patients suspected for human brucellosis.
Methods: The blood samples were collected from febrile patients suspected to have brucellosis. A total of 18 isolates were obtained from 102 blood samples subjected to culture. The characterization of these 18 isolates was done by growth on Brucella specific medium, biochemical reactions, CO2 requirement, H2S production, agglutination with A and M mono-specific antiserum, dye sensitivity to basic fuchsin and thionin. Further, molecular characterization of the isolates was done by amplification of B. melitensis species specific IS 711 repetitive DNA fragment and 16S (rRNA) sequence analysis. PCR-restriction fragment length polymorphism (RFLP) analysis of omp2 locus and IS711 gene was also done for molecular characterization.
Results: All 102 suspected samples were subjected to bacteria isolation and of these, 18 isolates could be recovered on blood culture. The biochemical, PCR and PCR-RFLP and 16s rRNA sequencing revealed that all isolates were of B. melitensis and matched exactly with reference strain B. melitensis 16M.
Interpretation & conclusions: The present study showed an overall isolation rate of 17.64 per cent for B. melitensis. There is a need to establish facilities for isolation and characterization of Brucella species for effective clinical management of the disease among patients as well as surveillance and control of infection in domestic animals. Further studies are needed from different geographical areas of the country with different level of endemicity to plan and execute control strategies against human brucellosis.
Keywords: Brucellosis - Brucella melitensis - PCR - PCR-RFLP - sequencing
|How to cite this article:|
Barua A, Kumar A, Thavaselvam D, Mangalgi S, Prakash A, Tiwari S, Arora S, Sathyaseelan K. Isolation & characterization of Brucella melitensis isolated from patients suspected for human brucellosis in India. Indian J Med Res 2016;143:652-8
|How to cite this URL:|
Barua A, Kumar A, Thavaselvam D, Mangalgi S, Prakash A, Tiwari S, Arora S, Sathyaseelan K. Isolation & characterization of Brucella melitensis isolated from patients suspected for human brucellosis in India. Indian J Med Res [serial online] 2016 [cited 2018 Mar 23];143:652-8. Available from: http://www.ijmr.org.in/text.asp?2016/143/5/652/187115
Brucellosis More Details, a zoonosis caused by the genus Brucella More Details is responsible for considerable human morbidity and causes enormous economic losses due to abortion and infertility in livestock. Brucellosis in humans occurs as an acute, sub-acute or chronic illness which develops from direct or indirect contact with animals or by consumption of unpasteurized milk, milk products or meat of infected animals. Six classical species of Brucella that differ in their host preference are B. abortus which preferentially infects cattle; B. melitensis infects sheep and goats; B. suis infects pigs; B. canis the dog; B. ovis, sheep and goats; and B. neotomae infects the desert wood rat. Later on, new species isolated from marine mammals namely B. ceti and B. pinnipedialis have been described. Two more species namely, B. microti (common vole; seals),, and B. inopinata from a human breast implant infection were also isolated and characterized as a new member of genus Brucella. A novel Brucella strain originating from wild native rodent species in North Queensland, Australia, and a Brucella isolate from two cases of stillbirth in non-human primates have also been described but not yet included in the genus Brucella,.
The low infection dose and easy transmission to humans via aerosols make Brucella species a potential biological warfare agent9,10. In the absence of reliable, reproducible and validated molecular tests for confirmation, culture isolation is still considered as gold standard for brucellosis. A combination of biochemical, serological and molecular methods is needed for reliable identification and biotyping of Brucella. Biochemical tests like CO2 requirement, H2S production, dye sensitivity, urease, oxidase, catalase tests are also used for identification of Brucella species. In addition, biotyping method based on agglutination with mono-specific A and M antiserum is also helpful in characterization of isolates. Several serological tests like serum tube agglutination test (STAT), Rose Bengal plate test (RBPT), 2-mercaptoethanol (2ME), complement fixation test (CFT) and enzyme linked immunosorbent assay (ELISA) are used for the diagnosis of human brucellosis. The major disadvantages with these serological tests include the presence of background antibodies from endemic areas and no differentiation of acute cases from previous exposure. Numerous PCR based assays have been developed and evaluated ranging from identification of the genus Brucella (Genus-Specific PCR assay) to single unique genetic locus that is highly conserved in Brucella species (e.g. 43 kDa omp, BCSP31, IS6501/711 or 16S rRNA genes),,. In the present study an attempt was made to characterize the isolates of Brucella obtained from patients suspected for brucellosis using biochemical, serological and molecular methods.
| Material & Methods|| |
This study was conducted in the Microbiology Division, Defence Research and Development Establishment (DRDE), Gwalior, on the isolates collected at the department of Microbiology, BLDEU's Shri B.M. Patil Medical College, Bijapur, Karnataka, India. A total of 496 febrile patients from endemic region of Bijapur were selected consecutively during the period 2010-2012. Of these, 102 high risk patients (5-55 yr) were identified based on the history given by them that included animal exposure, raw milk ingestion and clinical symptoms such as fever, headache, nausea, vomiting, backache, joint pains. blood samples (15 ml) were collected aseptically from these 102 patients. Five ml of blood in duplicate was immediately used for blood culture and the remaining was saved for separation of serum for serological testing of brucellosis. All serological tests and isolation were performed at Shri B.M. Patil Medical college, Bijapur, Karnataka, and serum samples and culture were sent to DRDE for further biochemical and molecular confirmation of isolates.
Serological tests with patients' serum samples: The serum sample collected was subjected to conventional serological tests (STAT, 2ME and RBPT) to check for the presence of anti-brucella antibodies. In STAT, patient serum was serial diluted from 1:10 to 1:1280 with 0.5 per cent phenol saline, Brucella antigen (Division of Biological products, IVRI, Izatnagar, India) was added and incubated at 37°C for 24 h. The maximum dilution that exhibited 50 per cent agglutination was considered as the end point of serum activity and recorded as the titre of antibodies present in the individual against Brucella. RBPT and 2ME tests were done as per the protocol described earlier,,.
Isolation of bacterial culture: The isolation of bacteria from patient's blood was performed using conventional Castaneda culture technique. Five ml of blood was inoculated aseptically into 50 ml broth phase of Castaneda biphasic medium consisting of brain heart infusion (BHI) agar and broth (Hi-media, Mumbai) in duplicate. The contents were mixed well and tapped daily to allow the blood-broth mixture to flow over the agar slant. The bottles were then incubated in upright position in incubator at 37°C, one with and another without CO2 atmosphere and examined daily for growth. If no colonies were observed, the bottles were tilted and re-incubated and the cycle was repeated for a minimum of 30 days. If still no growth was observed after 30 days, the samples were considered negative and discarded.
Microbiological and biochemical identification of isolates: All isolates were grown on Brucella selective medium (Hi-media, Mumbai) and studied for colony morphology, culture characteristics like smooth or rough colony by examination under inverted microscope. The cultures were subjected to Gram staining. The isolates were characterized by biochemical tests such as oxidase, catalase, urease, CO2 requirement, H2S production, methyl red, indole and sensitivity to thionin, basic fuchsin and safranin dyes. B. melitensis biotype I expresses M antigen; therefore, all isolates were also reacted with monospecific A and M agglutinating antiserum (Veterinary laboratories agency, Addlestone, UK) for culture identification.
The standard bacterial strains of Brucella species used in this study for comparison were B. melitensis 16M and B. abortus S. Both these species were maintained in 30 per cent glycerol stocks at -80°C as well as in liquid nitrogen.
DNA isolation: DNA of all the isolates and standard strains were isolated using conventional phenol: chloroform: isoamylalcohol method. Purity and the concentration of DNA were checked spectrophotometrically at an absorbance 260/280 nm and visualized under UV on 0.8 per cent agarose gel electrophoresis.
PCR amplification of 16S rRNA and sequence analysis: PCR amplification of 16S rRNA gene of Brucella species was done in two fragments using the primers as described earlier. The PCR reactions were standardized in 25 µl reaction mixture of 200 µM each dNTPs, 1.5 mM of MgCl2, 10 pmol of each primers, 1 U of Taq polymerase and 50 ng of DNA in 1x PCR buffer. All the PCR reagents used in the study were procured from MBI, Fermentas, USA. The PCR cycling conditions were standardized as initial denaturation of 95°C for 4 min followed by 30 cycles of denaturation at 95°C for 50 sec, annealing at 58°C for 50 sec and extension of 72°C for 1 min and then final extension at 72°C for 10 min. The PCR products were run on 1.2 per cent agarose gel, stained with ethidium bromide and visualized under gel documentation system (Alpha innotech, USA). The PCR products were purified using QIAGEN gel extraction kit, USA and the purified PCR products were sequenced from both ends using forward and reverse primers in separate reaction by dideoxy chain termination method in ABI 3730 sequencer (Applied biosystem, USA). The alignment of DNA sequences was performed by using software DNA star 9.0 version (www.dnastar.com) along with the reference sequence of B. melitensis 16M (GenBank accession no. DQ845343). The BLAST analysis of the aligned sequences was also done to compare with other reported sequences of Brucella species. The 16S rRNA sequence of 18 isolates were submitted to GenBank and assigned accession numbers JF939172 to JF939189.
PCR amplification of omp2a and restriction fragment length polymorphism (RFLP) analysis: The 1233 bp omp2a gene was amplified and PCR reaction was standardized using the primers and the protocol as described above for 16S rRNA. The Brucella omp2a gene was PCR amplified, purified using QIAGEN gel extraction kit and digested with Hinf I, Alu I, Ban I and Pst I restriction enzymes. The restriction digestion reaction was standardized in 30 µl reaction mixture of 10 µl of purified omp2a PCR product, 3 µl of 10x buffer, and one unit of restriction enzyme (Fast digest, Fermentas). The reaction mixtures was incubated at 37°C for one h and digested products were electrophoresed in 2 per cent agarose gel, stained with ethidium bromide and visualized under gel UV in documentation system (Alpha innotech, USA).
PCR amplification of IS711 gene, sequence and RFLP analysis: The species level confirmation of the isolates was done by PCR amplification of the 733 bp B. melitensis-specific DNA fragment of IS711 repetitive genetic element. The amplification of 733 bp B. melitensis-specific DNA fragment was carried out using specific primers. The PCR conditions were optimized as in the case of 16S rRNA except annealing at 68°C. The amplified products were run on 1.2 per cent agarose gel, stained with ethidium bromide and visualized under gel documentation system. Sequencing of IS711 gene was also performed as per protocol described above. The BLAST analysis of the final sequences obtained for each isolates was done and compared with other reported sequences of Brucella species in NCBI database (www.ncbi.nlm.nih.gov).
The 733 bp B. melitensis-specific IS711 gene was also used for PCR-RFLP analysis for confirmation of isolates as B. melitensis. The IS711 gene was PCR amplified and purified using QIAGEN gel extraction kit and digested with Hinf I and Tru I restriction enzymes ([Table I]). The restriction digestion reaction was performed in a 30 μl reaction volume containing 10 μl purified IS711 PCR product, 3 μl of 10x buffer, and 1U of restriction enzyme (Fast digest, Fermentas). The reaction mixture was incubated at 37°C for 1 h and the digested products were electrophoresed in 2 per cent agarose gel stained with ethidium bromide and visualized under UV in gel documentation system (Alpha innotech, USA). The sequences of IS711 gene of all 18 isolates were submitted to GenBank and assigned accession numbers JF939142 to JF939150, JF939153 to JF939157 and JF939161 to JF939169. Phylogenetic analysis of isolates was done based on IS711 sequence, closest match of the deduced sequences of IS711 isolates was determined by BLAST search and a phylogenetic tree were constructed by neighbor-joining method using Mega software version 5 with 1000 bootstrap (www.megasoftware.net).
|Table I: Restriction fragment length polymorphism analysis (www.neb.com)|
Click here to view
| Results|| |
Isolation of Brucella and biotyping: Of the 102 samples subjected to blood culture, 18 isolates were obtained with an overall isolation rate of 17.64 per cent. These 18 cultures were initially identified as Brucella species based on gram staining and colony morphology. The colonies grown on Brucella selective medium were round, convex, with smooth margin, translucent, honey-coloured, glistening and gram-negative coccobacilli. These isolates were positive for catalase, oxidase, and urease tests and negative for methyl red, indole, CO2 requirement and H2S production. The biochemical tests profile of these 18 isolates was identical and matched with that of standard strain B. melitensis 16M. The isolates were positive with Brucella anti-M monospecific serum confirming that all 18 isolates belonged to B. melitensis biotype 1. The isolates were also able to grow in presence of dyes namely thionin, basic fuchsin and safranin.
Serological characterization: The serum samples of 18 patients who were positive for culture isolation also showed significant titre with STAT (≥160 IU), 2ME (≥80 IU) and were positive by RBPT, confirming the presence of anti-Brucella antibody in these patients.
Molecular characterization: The PCR results for 16S rRNA amplification showed amplification of 839 bp product with first primer set and 699 bp with second primer set. PCR amplification of Omp2a gene amplified 1233 bp products, and 733 bp for B. melitensis specific IS711 gene along with the reference strain of B. melitensis 16M. For further confirmation of isolates, PCR-RFLP of omp2a locus and IS711 was performed. Omp2a gene was digested with Pst I, Ban I and Hinf I restriction enzymes revealed similar restriction profiles in all isolates and also matched with B. melitensis 16M [Table I]. The restriction profile of all isolates did not match with B. abortus S19 reference strain. Similarly, the restriction pattern generated for IS711 gene when digested with Hinf I and Tru I restriction enzymes was similar for all isolates and matched with B. melitensis 16M reference strain [Table I]. Sequencing analysis of 16S rRNA and IS711 gene was done for 18 isolates using dideoxy chain termination and the obtained sequences were aligned and matched with B. melitensis 16M reference. The BLAST analysis of deduced sequences of 16S rRNA revealed 100 per cent similarity with Brucella species, whereas IS711 BLAST analysis revealed nearest match with B. melitensis species thereby confirming that all the isolates belonged to B. melitensis 16M (biotype1).
Phylogenetic analysis: The phylogenetic tree based on 733 bp sequence of IS711 repetitive genetic element for all isolates was constructed. IS711 gene sequencing and phylogenetic analysis revealed that all 18 isolates closely matched with B. melitensis 16M standard strain and were of clonal origin. One of the isolates from Israel also showed 100 per cent similarity to the isolates of present study in clade 1 [Figure 1]. The isolates of B. melitensis from other countries are placed into different clades along with the other species of Brucella and showed dissimilarity with the present isolates [Figure 1].
|Figure 1: Neighbor joining tree based on IS711 gene sequences of B. melitensis isolates and related reference strains constructed with 1000 bootstrap using Mega software version 5. The bootstrap values are given at the nodes.|
Click here to view
| Discussion|| |
Among all the Brucella species, B. melitensis is mostly responsible for human brucellosis and prevalent in Southeast Asian countries including India. Isolation and genotyping of the bacterial species is essential to know the exact incidence of a disease in a region and also to plan epidemiological studies, control and eradication programmes. The identification of isolates from culture is the gold standard in diagnosis of brucellosis both in humans and animals. Molecular confirmation by PCR utilizing different gene targets has become the most common approach for confirmation of human and animal isolates,. In this study, we reported the isolation of B. melitensis from human patients suspected for human brucellosis and characterized the isolates by conventional biochemical and serological methods. The molecular confirmation was done by PCR, PCR-RFLP and gene sequencing analysis. Sequence analysis of 16S rRNA gene is extensively used for molecular detection or taxonomic analysis of different bacterial species; 16SrRNA gene sequence among Brucella species is significantly conserved and it has been reported that 16S rRNA gene sequencing is a reliable tool for rapid genus level identification of Brucella. The omp2a and omp2b genes encoding 36 kDa outer membrane proteins (OMPs) of Brucellae are reported to be highly diverse among Brucella spp, biovars and strains. The present study also showed that PCR-RFLP at omp2a locus was an important tool in identification and biotyping of Brucella species. The amplification of 733bp repetitive genetic element of IS711 and sequencing are highly suitable and practically applicable for molecular characterization of B. melitensis isolates from human patients. The successful isolation protocol followed by the conventional biochemical tests and confirmation by PCR, PCR-RFLP and sequence analysis of 16S rRNA and IS711 genes followed in this study could be a practical approach for not only disease diagnosis but also as a model for surveillance of human brucellosis in India.
In India, only a few studies, have addressed the importance of brucellosis as a public health problem. The disease may be overlooked and misdiagnosed because of the difficult diagnosis and lack of experience with the laboratory testing. It has also been estimated that the true incidence of brucellosis may be 25 times higher than the reported incidence due to misdiagnosis and underreporting. Our results indicate that human brucellosis can be a common public health problem in many of the states of India. The disease is normally associated with persons who are in close contact with animals like shepherds and veterinarian and those who have the habit of consumption of raw milk of sheep and goat. more studies from different geographical regions of the country on isolation of this important bacterial species are needed. In addition, facilities and expertise required for isolation and characterization should be established in endemic areas so as to help in prompt diagnosis and treatment as well as to understand the actual incidence of human brucellosis in the country.
| Acknowledgment|| |
Authors thank Dr M.P. Kaushik, Director, Defence Research and Development Establishment, Gwalior and Dr Urmil Tuteja, Head, Microbiology Division for their valuable support. The authors also thank the Principal, technical staff and clinicians Drs M.S. Biradar, R.C. Bidari, L.H. Bidari, S.V. Patil of BLDEU'S Medical College, Bijapur, Karnataka for their support. The first author (AB) acknowledges the Indian Council of Medical Research (ICMR), New Delhi, for financial support.
| References|| |
Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis
2006; 6 : 91-9.
Tiller RV, Gee JE, Frace MA, Taylor TK, Setubal JC, Hoffmaster AR, et al.
Characterization of novel Brucella
strains originating from wild native rodent species in North Queensland, Australia. Appl Environ Microbiol
2010; 76 : 5837-45.
Jahans KL, Foster G, Broughton ES. The characterisation of Brucella
strains isolated from marine mammals. Vet Microbiol
1997;57 : 373-82.
Whatmore AM. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect Genet Evol
2009; 9 : 1168-84.
Scholz HC, Hubalek Z, Sedlacek I, Vergnaud G, Tomaso H, Al Dahouk S, et al. Brucella
microti sp. nov., isolated from the common vole Microtus arvalis. Int J Syst Evol Microbiol
2008;58 : 375-82.
Foster G, Osterman BS, Godfroid J, Jacques I, Cloeckaert A. Brucella
ceti sp. nov. and Brucella
pinnipedialis sp. nov. for Brucella
strains with cetaceans and seals as their preferred hosts. Int J Syst Evol Microbiol
2007;57 : 2688-93.
Scholz HC, Nöckler K, Göllner C, Bahn P, Vergnaud G, Tomaso H, et al. Brucella
inopinata sp. nov. isolated from a breast implant infection. Int J Syst Evol Microbiol
2010;60 : 801-8.
Schlabritz-Loutsevitch NE, Whatmore AM, Quance CR, Koylass MS, Cummins LB, Dick EJ, et al.
A novel Brucella
isolate in association with two cases of stillbirth in non-human primates- first report. J Med Primatol
2009; 38 : 70-3.
Pappas G, Panagopoulou P, Christou L, Akritidis N. Brucella
as a biological weapon. Cell Mol Life Sci
2006; 63 : 2229-36.
Hoover DL, Friedlander A. Brucellosis. In: Zajtchuk R, editors. Textbook of military medicine: medical aspects of chemical and biological warfare. Washington, DC: US Department of the Army, Surgeon General, and the Bor- den Institute; 2010. p. 513-21.
Affi MM, Abdul-Raouf UM, El-Bayoumy EM, Montasser AM, Mohamad HA. Isolation and biotyping of Brucella melitensis
from upper Egypt. J Am Sci
Mantur B, Parande A, Amarnath S, Patil G, Walvekar R, Desai A, et al.
ELISA versus conventional methods of diagnosing endemic brucellosis. Am J Trop Med Hyg
2010;83 : 314-8.
Halling SM, Tatum FM, Bricker BJ. Sequence and characterization of an insertion sequence, IS711
, from Brucella
1993; 133 : 123-7.
Casanas MC, Queipo-Ortuno MI, Rodriguez-Torres A, Orduna A, Colmenero JD, Morata P. Specificity of a polymerase chain reaction assay of a target sequence on the 31-kilodalton Brucella
antigen DNA used to diagnose human brucellosis. Eur J Clin Microbiol Infect Dis
2001; 20 : 127-31.
Mugizi DR, Muradrasoli S, Boqvist S, Erume J, Nasinyama GW, Waiswa C, et al.
Isolation and molecular characterization of Brucella
isolates in cattle milk in Uganda. Biomed Res Intl 2015, article ID 720413, 9 pages.
Mangalgi S, Sajjan A, Mohite ST. Seroprevalence of Brucellosis among blood donors of Satara District, Maharashtra. J Krishna Inst Med Sci Univ
2012; 1 : 55-60.
Aliskan H. The value of culture and serological methods in the diagnosis of human brucellosis. Mikrobiyol Bul
2008; 42 : 185-95.
Mantur BG, Biradar MS, Bidri RC, Mulionani MS, Verrappa, Kariholu P, et al.
Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. J Med Microbiol
2006; 55 : 897-903.
Mantur BG, Mangalgi SS. Evaluation of conventional Castaneda and lysis centrifugation blood culture techniques for diagnosis of human brucellosis. J Clin Microbiol
2004; 42 : 4327-8.
Maymona AM, Mohamed TS, Abdulwahab YA, Musa TM. Phenotypic characterization of Brucella melitensis
isolated from livestock in Abu Dhabi Emirate. Afr J Microbiol Res
2014; 8 : 3523-8.
Bundle DR, Cherwonogrodzky JW, Gidney MA, Meikle MA, Perry MB, Peters T. Definition of Brucella
A and M epitopes by monoclonal typing reagents and synthetic oligosaccharides. Infect Immun
1989;57 : 2829-36.
Sambrook J, Russell dW. Molecular cloning, a laboratory manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
Unver A, Erdogan HM, Atabay HI, Sahin M, Celebi O. Isolation, identification, and molecular characterization of Brucella melitensis
from aborted sheep fetuses in Kars, Turkey. Revue Med Vet
2006; 157 : 42-6.
Prakash A, Thavaselvam F, Kumar A, Kumar A, Arora S, Tiwari S, et al.
Isolation, identification of Burkholderia pseudomallei from soil of coastal region of India. Springerplus
2014; 3 : 438.
Tien N, Sung Y, Chang Y, You B, Liang M, Lim Y, et al.
The medical diagnostic approaches with phylogenetic analysis for rare Brucella
spp. diagnosis in Taiwan. Biomedicine (Taipei) 2015; 5 : 9.
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol
2011; 28 : 2731-9.
Bamaiyi PH, Hassan L, Khairani-Bejo S, Zainal Abidin M. update on Brucellosis in Malaysia and Southeast Asia. Malaysian J Vet Res
2014; 5 : 71-82.
Herman L, De Ridder H. Identification of Brucella
spp. by using the polymerase chain reaction. Appl Environ Microbiol
1992; 58 : 2099-101.
Gee JE, De BK, Levett PN, Whitney AM, Novak RT, Popovic T. Use of 16 S rRNA genes sequencing for rapid confirmatory identification of Brucella
isolates. J Clin Microbiol
2004; 42 : 3649-54.
Fitch TA, Bearden SW, Sowa BA, Marquis H. Genetic variation at the omp
porin locus of the brucellae: species specific markers. Mol Microbiol
1990;4 : 1135-42.
Smith HL, Kadri SM. Brucellosis in India: a deceptive infectious disease. Indian J Med Res
2005; 122 : 375-84.
Mrunalini N, Reddy MS, Ramasastry P, Rao MR. Seroepidemiology of human brucellosis in Andhra Pradesh. Indian Vet J
2004; 81 : 744-7.
Yohannes M, Gill JP. Seroepidemiological survey of human brucellosis in and around Ludhiana, India. Emerg Health Threats J
2011; 4 : 10.
|This article has been cited by|
||Caprine brucellosis: A historically neglected disease with significant impact on public health
| ||Carlos A. Rossetti,Angela M. Arenas-Gamboa,Estefanía Maurizio,Mazin Barry |
| ||PLOS Neglected Tropical Diseases. 2017; 11(8): e0005692 |
|[Pubmed] | [DOI]|
||The clinical features of 590 patients with brucellosis in Xinjiang, China with the emphasis on the treatment of complications
| ||Bin Jia,Fengbo Zhang,Ying Lu,Wenbao Zhang,Jun Li,Yuexin Zhang,Jianbing Ding,Mazin Barry |
| ||PLOS Neglected Tropical Diseases. 2017; 11(5): e0005577 |
|[Pubmed] | [DOI]|
||Evaluation of recombinant porin (rOmp2a) protein as a potential antigen candidate for serodiagnosis of Human Brucellosis
| ||Prachi Pathak,Ashu Kumar,Duraipandian Thavaselvam |
| ||BMC Infectious Diseases. 2017; 17(1) |
|[Pubmed] | [DOI]|